Yoshida M, Kawabe K, Homma Y. Silodosin, a new effective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia: Results of a phase 3 randomized, placebo-controlled, double-blind study. San Antonio, Texas, USA: American Urological Association Annual Meeting; Publishing# 1642. May 2005. p. 21-6.
Murata S, Taniguchi T, Takahashi M, Okada K, Akiyama K, Muramatsu I. Tissue selectivity of KMD-3213, an α1adrenoceptor antagonist, in human prostate and vasculature. J Urol 2000; 164: 578-83.